Anita Mattson, associate professor of chemistry and biochemistry at Worcester Polytechnic Institute, received a $1.7-million award from NIH to develop a new class of catalysts that could make it possible to reliably synthesize organic compounds that hold the promise of treating cancers that have become resistant to commonly used chemotherapy. The catalysts may also open the door to a new approach to discovering drugs for cancer and other diseases.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe